Want a printable/shareable version of the cards?
Check out our cards here: hubs.la/Q041jJqD0
@vectorbuilder.bsky.social
VectorBuilder is a global leader in gene delivery technologies.
Want a printable/shareable version of the cards?
Check out our cards here: hubs.la/Q041jJqD0
Do you need a Valentineβs Day card for your lab mate or loved one? We made a few you can download, perfect for lab benches, desks, and sharing a little science love. π§¬π
09.02.2026 17:46 β π 0 π 0 π¬ 1 π 0π Annual Survey winners announced Wednesday, February 11 π
Keep an eye outβyou might see your name!
Thank you to everyone who shared feedback and helped shape whatβs next for VectorBuilder.
𧬠How do diseases initiate at the genetic level?
Our next Gene Delivery Seminar highlights how early genetic events are studied in vivo, with relevance to cancer biology and beyond.
Sign up now: us06web.zoom.us/webinar/regi...
Read more here: en.vectorbuilder.com/products-ser...
05.02.2026 16:08 β π 0 π 0 π¬ 0 π 0Last week, we highlighted how IVT RNA design optimization improves R&D performance. This week, weβre focusing on LNP-RNA delivery and how formulation and antibody conjugation enhance outcomes.
More next week on clinical applications!
On World Cancer Day, we honor patients and their families while recognizing the significant advances in cancer research and the work that remains to be done. Thatβs why we support scientists working to turn discoveries into real impact for all patients.
04.02.2026 15:46 β π 0 π 0 π¬ 0 π 0Congratulations to Ilia Kurochkin and the @cellreprolab.bsky.social on their publication introducing REPROcode, a platform for combinatorial transcription factor screening that enables controlled immune cell reprogramming toward distinct lineages.
02.02.2026 14:58 β π 0 π 0 π¬ 0 π 0This is your final opportunity to let us know whatβs working and where we can improve; our annual survey closes on January 31!
Your feedback directly informs the development of future VectorBuilder tools and improvements. Complete the survey for a chance to win up to $1,000 in store credit.
Register here: us06web.zoom.us/webinar/regi...
29.01.2026 15:06 β π 0 π 0 π¬ 0 π 0𧬠Did you know acute lymphoblastic leukemia is the most common childhood cancer? But how does it begin?
Join our next Gene Delivery Seminar with @jamesrallen.bsky.social, @hhmi-science.bsky.social Hanna Gray Fellow and incoming faculty at @mayoclinic.org, on February 19.
CRISPR therapies are no longer a pipe dream. As genome editing moves into the clinic, delivery is now the real challenge.
In her latest article, Dr. Connie Rich explores how delivery design shapes which CRISPR therapies reach patients safely and at scale.
Read here: www.calameo.com/read/0061133...
Read more about it here: en.vectorbuilder.com/products-ser...
27.01.2026 17:48 β π 0 π 0 π¬ 0 π 0Have you met VectorBuilderβs end-to-end IVT RNA platform? This week, weβre highlighting how our IVT RNA design optimization strategies support performance and consistency throughout the R&D process.
Stay tuned next week as we explore LNP delivery!
A reminder that our Annual User Survey is still open, but not for long. Your feedback plays a key role in shaping future VectorBuilder improvements.
Take a few minutes to share your experience and enter to win store credit prizes up to $1,000.
If tissue clearing or whole-sample imaging is something youβre curious about, we hope you can join us.
Register here: us06web.zoom.us/webinar/regi...
Our first Gene Delivery Seminar of the year kicks off TODAY! Dr. @cristina-mtz-glz.bsky.social will share practical insights on choosing tissue-clearing approaches and utilizing advanced imaging to visualize intact samples in 3D.
22.01.2026 14:30 β π 1 π 1 π¬ 1 π 0You spoke. We listened. New Updates. π§¬
Since launching in 2024, VectorBee has continued to expand its tools for sequence analysis, vector design, and molecular cloning. If you havenβt used our FREE software yet, check out why scientists are buzzing about it: www.vectorbee.com/en/ π
Meet Ahlem Zaghmi!
From biology to PEG chemistry, Ahlemβs favorite project explored how PEG-grafted enzymes influence therapeutic potential in ischemiaβchallenging, humbling, and deeply rewarding.
𧬠Open Lab Hours | Free 1:1 PhD sessions
π
Feb 5 & 10: calendly.com/ahlemzaghmi-...
If you havenβt had a chance yet, thereβs still time to share your feedback and help shape the next wave of VectorBuilder tools and updates. Complete the survey by January 31 to enter for a chance to win up to $1,000 in store credit.
docs.google.com/forms/d/e/1F...
Reminder! Donβt miss our seminar with Dr. Cristina Martinez Gonzalez as she introduces novel tissue-clearing strategies and key considerations for selecting the right protocol for different samples and research objectives.
Register here! us06web.zoom.us/webinar/regi...
By studying the NFR5Ξ± gene, the work connects nodulation, root hair formation, & nutrient uptake, offering insights relevant to sustainable agriculture. π±
Read the publication here: acsess.onlinelibrary.wiley.com/doi/full/10....
New study from the Torkamaneh lab @ulaval.ca uses CRISPR knockouts to show how nitrogen fixation & root development are genetically linked in soybean.
13.01.2026 15:06 β π 1 π 0 π¬ 1 π 0Register here! us06web.zoom.us/webinar/regi...
09.01.2026 16:45 β π 0 π 0 π¬ 0 π 0Interested in tissue-clearing techniques to study intact samples in 3D? Catch Dr. Cristina Martinez Gonzalez's talk (@cristina-mtz-glz.bsky.social) as she introduces novel tissue-clearing strategies & key considerations for selecting the right protocol for different samples & research objectives.
09.01.2026 16:45 β π 1 π 1 π¬ 1 π 2Ready to participate?
Take a few minutes to tell us whatβs working well and what could be better.
Take the survey & enter to win: hubs.la/Q03-2LfH0
Thank you for helping shape the future of VectorBuilder!
As a thank-you, weβll be selecting 8 winners for store credit prizes:
β’ 5 winners will receive $100
β’ 2 winners will receive $250
β’ 1 grand prize winner will receive $1,000
π£ Share Your Thoughts and Boost Your Research!
Our Annual User Survey is now live, and weβd love to hear from you. Your feedback directly helps us improve the tools, services, and support that power your research, including VectorBee upgrades.
In a new Forbes commentary, our COO, Kristofer Mussar, reflects on what customer support looks like in the age of AI and why automation alone isnβt enough.
Read the full piece to learn how balancing technology and humanity can build real trust: www.forbes.com/councils/for...
The program leverages VectorBuilderβs proprietary intravitreal capsid technology to enable a minimally invasive treatment. IKAR-003 combines neuroprotection and complement modulation to help prevent progression to irreversible vision loss.
Read the full announcement:
hubs.la/Q03ZFsfD0